FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035339432> ?p ?o ?g. }

• W3035339432 abstract "Abstract Inflammation and autophagy occur during hepatic fibrosis development caused by various pathogens, and effectively curbing of autophage may delay the occurrence of hepatic fibrosis. The current study aimed to unravel the inhibitory effects of Ginsenoside Rg3 (G-Rg3) on inflammation-mediated hepatic autophagy to curb hepatic fibrosis caused by thioacetamide (TAA)-induced subacute and chronic hepatic injury. TAA is mainly metabolized in the liver to cause liver dysfunction. After intraperitoneal injection of TAA for 4 or 10 weeks (TAA-chronic mouse models), severe inflammatory infiltration and fibrosis occurred in the liver. Treatment with G-Rg3 alleviated hepatic pathological changes and reversed hepatic fibrosis in the TAA-chronic models with decreased deposition of collagen fibers, reduced expression of HSCs activation marker (α-SMA), and reduced secretion of profibrogenic factors (TGF-β1). G-Rg3 decreased expressions of autophagy-related proteins in mice of TAA-chronic models. Notably, G-Rg3 inhibited the survival of activated rat hepatic stellate cells (HSC-T6), but had no cytotoxicity on human hepatocytes (L02 cell lines). G-Rg3 dose-dependently inhibited autophagy in vitro with less expression of p62 and fewer LC3a transformation into LC3b in inflammatory inducer lipopolysaccharide (LPS)-induced rat HSC-T6 cells. Furthermore, G-Rg3 enhanced the phosphorylation of phosphatidylinositol 3-kinase (PI3K) and protein kinase B (Akt) in vivo and in vitro. Besides, mTOR inhibitor Rapamycin and PI3K inhibitors LY294002 were employed in LPS-treated HSC-T6 cell cultures to verify that Rg3 partially reversed the increase in autophagy in hepatic fibrosis in vitro. Taken together, G-Rg3 exerted anti-fibrosis effect through the inhibition of autophagy in TAA-treated mice and LPS-stimulated HSC-T6 cells. These data collectively unravel that G-Rg3 may serve a promising anti-hepatic fibrosis drug." @default.
• W3035339432 created "2020-06-19" @default.
• W3035339432 creator A5017950579 @default.
• W3035339432 creator A5023682328 @default.
• W3035339432 creator A5025033944 @default.
• W3035339432 creator A5042457808 @default.
• W3035339432 creator A5051453382 @default.
• W3035339432 creator A5057492548 @default.
• W3035339432 creator A5063253432 @default.
• W3035339432 creator A5079310807 @default.
• W3035339432 creator A5080733133 @default.
• W3035339432 date "2020-06-12" @default.
• W3035339432 modified "2023-10-16" @default.
• W3035339432 title "Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway" @default.
• W3035339432 cites W1967604507 @default.
• W3035339432 cites W1979215811 @default.
• W3035339432 cites W1981817858 @default.
• W3035339432 cites W1982484050 @default.
• W3035339432 cites W2000369852 @default.
• W3035339432 cites W2005270729 @default.
• W3035339432 cites W2016085979 @default.
• W3035339432 cites W2017925532 @default.
• W3035339432 cites W2018251493 @default.
• W3035339432 cites W2027262109 @default.
• W3035339432 cites W2032639324 @default.
• W3035339432 cites W2051849819 @default.
• W3035339432 cites W2065666473 @default.
• W3035339432 cites W2075290880 @default.
• W3035339432 cites W2080150721 @default.
• W3035339432 cites W2085442981 @default.
• W3035339432 cites W2095046356 @default.
• W3035339432 cites W2109034822 @default.
• W3035339432 cites W2111288662 @default.
• W3035339432 cites W2111754392 @default.
• W3035339432 cites W2120821168 @default.
• W3035339432 cites W2124273275 @default.
• W3035339432 cites W2132249975 @default.
• W3035339432 cites W2137464881 @default.
• W3035339432 cites W2138915349 @default.
• W3035339432 cites W2139166152 @default.
• W3035339432 cites W2139256273 @default.
• W3035339432 cites W2142317734 @default.
• W3035339432 cites W2153068313 @default.
• W3035339432 cites W2163036793 @default.
• W3035339432 cites W2165062244 @default.
• W3035339432 cites W2171925512 @default.
• W3035339432 cites W2347070364 @default.
• W3035339432 cites W2461534763 @default.
• W3035339432 cites W2511609099 @default.
• W3035339432 cites W2562949639 @default.
• W3035339432 cites W2599822883 @default.
• W3035339432 cites W2605212331 @default.
• W3035339432 cites W2621287519 @default.
• W3035339432 cites W2624796717 @default.
• W3035339432 cites W2725264709 @default.
• W3035339432 cites W2769684125 @default.
• W3035339432 cites W2784644952 @default.
• W3035339432 cites W2795855957 @default.
• W3035339432 cites W2902644109 @default.
• W3035339432 cites W2909653888 @default.
• W3035339432 cites W2914436528 @default.
• W3035339432 cites W2938588396 @default.
• W3035339432 cites W2979841778 @default.
• W3035339432 cites W2983478501 @default.
• W3035339432 cites W4211173486 @default.
• W3035339432 doi "https://doi.org/10.1038/s41419-020-2597-7" @default.
• W3035339432 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7293224" @default.
• W3035339432 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32532964" @default.
• W3035339432 hasPublicationYear "2020" @default.
• W3035339432 type Work @default.
• W3035339432 sameAs 3035339432 @default.
• W3035339432 citedByCount "42" @default.
• W3035339432 countsByYear W30353394322020 @default.
• W3035339432 countsByYear W30353394322021 @default.
• W3035339432 countsByYear W30353394322022 @default.
• W3035339432 countsByYear W30353394322023 @default.
• W3035339432 crossrefType "journal-article" @default.
• W3035339432 hasAuthorship W3035339432A5017950579 @default.
• W3035339432 hasAuthorship W3035339432A5023682328 @default.
• W3035339432 hasAuthorship W3035339432A5025033944 @default.
• W3035339432 hasAuthorship W3035339432A5042457808 @default.
• W3035339432 hasAuthorship W3035339432A5051453382 @default.
• W3035339432 hasAuthorship W3035339432A5057492548 @default.
• W3035339432 hasAuthorship W3035339432A5063253432 @default.
• W3035339432 hasAuthorship W3035339432A5079310807 @default.
• W3035339432 hasAuthorship W3035339432A5080733133 @default.
• W3035339432 hasBestOaLocation W30353394321 @default.
• W3035339432 hasConcept C126322002 @default.
• W3035339432 hasConcept C134018914 @default.
• W3035339432 hasConcept C176891718 @default.
• W3035339432 hasConcept C185592680 @default.
• W3035339432 hasConcept C190283241 @default.
• W3035339432 hasConcept C203014093 @default.
• W3035339432 hasConcept C203522944 @default.
• W3035339432 hasConcept C2776914184 @default.
• W3035339432 hasConcept C2780559512 @default.
• W3035339432 hasConcept C2993667909 @default.
• W3035339432 hasConcept C502942594 @default.
• W3035339432 hasConcept C55493867 @default.
• W3035339432 hasConcept C62478195 @default.

• next